Wayne State University, Karmanos Cancer Institute — Detroit, Michigan

Wayne State University, Karmanos Cancer Institute is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Wayne State University, Karmanos Cancer Institute has participated in 4 clinical trials.

Therapeutic areas: T-cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepato-splenic T-cell Lymphoma.

Sponsors: Deepa Jagadeesh, Symphony Evolution, Inc., Array Biopharma, now a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Wayne State University, Karmanos Cancer Institute?

Wayne State University, Karmanos Cancer Institute has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Wayne State University, Karmanos Cancer Institute conducted?

Wayne State University, Karmanos Cancer Institute has 4 clinical trials on record. Their work covers T-cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepato-splenic T-cell Lymphoma.

Is Wayne State University, Karmanos Cancer Institute accredited by Crixeo Health?

Yes — Wayne State University, Karmanos Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Wayne State University, Karmanos Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.